EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-62487 | Healthcare
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Exosome Diagnostic and Therapeutic Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET
7.1 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA EXOSOME DIAGNOSTIC AND THERAPEUTIC MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Aethlon Medical, Inc
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Therapeutic Solutions International, Inc
16.3 ReNeuron Group plc
16.4 Immune Therapy Holdings AB
16.5 Cell Guidance Systems LLC
16.6 BioRegenerative Sciences
16.7 Evomic Science LLC
16.8 NorgenBiotek Corp
16.9 Exosome Diagnostics, Inc./Bio-Techne
16.10 MiltenyiBiotec
16.11 NanoSomix Inc. (U.S.)
16.12 Thermo Fisher Scientific Inc. (U.S.)
16.13 Malvern Instruments Ltd. (U.K,)
16.14 System Biosciences Inc. (U.S.)
16.15 NX Pharmagen (U.S.)
16.16 Sistemic Inc. (U.K.)
16.17 Capricor Therapeutics (U.S.)
16.18 Exiqon A/S (Denmark)
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
By ApplicationDiagnostic
Therapeutic
By Product
Instruments
Reagents
Software
By End-User
Hospitals
Cancer Institutes
Diagnostic Centers
Others
Companies
Aethlon Medical, Inc
Therapeutic Solutions International, Inc
ReNeuron Group plc
Immune Therapy Holdings AB
Cell Guidance Systems LLC
BioRegenerative Sciences
Evomic Science LLC
NorgenBiotek Corp
Exosome Diagnostics, Inc./Bio-Techne
MiltenyiBiotec
NanoSomix Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Malvern Instruments Ltd. (U.K,)
System Biosciences Inc. (U.S.)
NX Pharmagen (U.S.)
Sistemic Inc. (U.K.)
Capricor Therapeutics (U.S.)
Exiqon A/S (Denmark)
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.